13
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Anthrax Toxin: History and Recent Advances and Perspectives

Pages 41-88 | Published online: 28 Sep 2008

References

  • Graham-Smith G. S. Flies in relation to disease: non blood sucking flies 180–209. Cambridge University Press, Cambridge 1913
  • Mitzmain M. B. Experimental insect transmission of anthrax Public Health Rep. 1914; 29: 75
  • Morris H. Some carriers of anthrax infection. J. Am Vet. Med. Assoc. 1920; 56: 606
  • Davies J. C. A. A major epidemic of anthrax in Zimbabwe II Distribution of cutaneous lesions Cent. Afr. J. Med. 1983; 29: 8
  • McKendrick D. R. A. Anthrax and its transmission to humans Cent. Afr. J. Med. 1980; 26: 126
  • Turner M. Anthrax in Humans in Zimbabwe. Central African Journal of Med. 1980; 26(7)161
  • Turell M. J., Knudson G. B. Mechanical Transmission of Bacillus anthracis by Stable Flies (Stomoxys calcitrans) and Mosquitoes(Aedes aegypti and Aedes taeniorhynchus). Infect Immun. 1987; 55: 1859
  • Stephen J. Anthrax toxin. Pharmacol. Ther. 1981; 12: 501
  • Hedlund K. Bacterial Toxins. Handbook of Natural Toxins, M Hardegree, T U Anthony. Marcel Dekker, Inc., New York 1988; Vol 4: 371
  • Tigertt W. D. Anthrax, J. Hyg. 1980; 85: 415
  • Pasteur L. De patte nuation des virus et de leur rotour a la virulence. C. R. Acad. Sci. Agric. Bulg. 1881; 92: 429
  • Ginsburg N. N., Cherkasskiy B. L. Basic results in control of anthrax in USSR. Vestniki Akademii Nauk SSR 1967; 23: 61
  • Gefen N. Investigation of the reactogenicity, harmlessness and immunologic effectiveness of the aerosol method of immunization against anthrax in tests of human beings. Zh. Microbiol. Epidemiol. Immunobiol. 1969; 12: 81
  • Burgasov P. N., Cherkasskiy B. L. Immunization of man against anthrax using the jet injector method. Zh. Microbiol. Epidemiiol. Immunobiol. 1973; 8: 3
  • Lesnyak O. T., Saltykov R. A. Preparation of STI-1 anthrax strain exotoxin Zh. Micriobiol. Epidemiol. Immunobiol. 1974; 2: 110
  • Cherkasskiy B. L. Current problems in the prevention of anthrax. Zh. Microbiol. Epidemiol. Immunobiol. 1979; 8: 3
  • Coggins C. H. Weapons of Mass Destruction. Mil. Rev. 1963; 42: 43
  • Twining D. Sverdlovsk anthrax outbreak. Air Force Mag. 1981; 64: 124
  • Wright G. G., Hedberg M. A., Feinberg R. J. Studies on immunity in anthrax; in vitro elaboration of protective antigen by non proteolytic mutants of Bacillus anthracis. J. Exp. Med. 1951; 93: 523
  • Puziss M., Wright G. G. Studies on immunity in anthrax. X Gel absorbed protective antigen for immunization in man. J. Bacteriol. 1963; 85: 230
  • Albrink W. S., Brooks S. M., Biron R. E., Kopel M. Human inhalation anthrax, a report of three fatal cases. Am. J. Pathol. 1960; 36: 457
  • Rangel Gonzalez R. A.D.A. Bacillus anthracis meningitis. Neurology 1975; 25(6)525
  • Shanahan R. H., Grifin J. R., von Auersperg A. P. Anthrax meningitis; Report of a case of internal anthrax with recovery. Am. J. Clin. Pathol. 1947; 17: 719
  • Haight T. H. Anthrax meningitis: Review of literature and report of 2 cases with autopies. Am. J. Med. Sci. 1952; 224: 57
  • Tahernia A. C., Hashemi G. Survival in anthrax meningitis. Pediatrics 1972; 50: 329
  • Levy L. M., Baker N., Meyer Crosland M., Hampton P. J. Anthrax Meningitis in Zimbabwe. Central African J. of Med. 1981; 27: 101
  • Wright G. Anthrax Toxin in Microbiology 1975, D. Schessinger. American Society for Microbiology, Washington, D.C. 1975; 292
  • Stephen J. Anthrax Toxin in Pharmacology of Bacterial Toxins, F. Dorner, J. Drews. Pergamon Press, OxfordEngland 1986; 381
  • Smith H., Keppie J. Observations on experimental anthrax: Demonstration of a specific lethal factor produced in vivo by Bacillus anthracis. Nature 1954; 173: 869
  • Smith H., Tempest D. W., Stanley J. L., Harris-Smith P. W., Gallop R. C. The chemical basis of the virulence of Bacillus anthracis. VII Two components of the anthrax toxin: their relationship to known immunizing agressins. Br. J. Exp. Pathol. 1956; 37: 263
  • Smith H. The Biochemical Response to Bacterial Injury. The Biochemical Response to Injury, H. B. Stoner, C. J. Threfall. Blackwell Scientific, OxfordEngland 1960; 341
  • Dalldorf F. G., Beall F. A. Capillary thrombosis as a cause of death in experimental anthrax. Arch. Path. 1967; 83: 154
  • Dalldorf F. G., Beall F. A., Krigman M. R., Goyer R. A., Livingston H. L. Transcelllular permeability and thrombosis of capillaries in anthrax toxemia. An electron microscopic and biochemical study. Lab. Invest. 1969; 21: 42
  • Fish D. C., Klein F., Lincoln R. E., Walker J. S., Dobbs J. P. Pathophysiological changes in the rat associated with anthrax toxin. J. Infect. Dis. 1968; 118: 114
  • Vick J. A., Lincoln R. E., Klein F., Mahlandt B. G., Walker J. S., Fish D. C. Neurological and physiological responses of the primate to anthrax toxin. J. Inf. Dis. 1968; 118: 85
  • Kasihiba S., Morilshima T., Kato K., Shima M., Amono T. Leucotoxic substance produced by Bacillus anthracis. Biken's J 1959; 2: 97
  • Ristroph J. D., Ivins B. E. Elaboration of Bacillus anthracis antigens in a new chemically defined media. Inf. Immun 1983; 39: 483
  • Leppla S. H. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations in eucaryotic cells. Proc. Natl. Acad. Sci. USA 1982; 79: 3162
  • Mikesell P., Ivins B. E., Ristroph J. D., Dreier T. M. Evidence for Plasmid-Mediated Toxin Production in Bacilllus anthracis. Inf. Immun. 1983; 39: 371
  • Vodkin M. H., Leppla S. H. Cloning of the Protective antigen Gene of Bacillus anthracis. Cell 1983; 34: 693
  • Mock M., Labruyere E., Glaser P., Danchin A, Ullmann A. Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli. Gene 1988; 64(2)277
  • Robertson D. L., Leppla S. H. Molecular cloning and expression in Escherichia coli or the lethal factor gene of Bacillus anthracis. Gene 1986; 44(1)71
  • Cataldi A., Labruyere E., Mock M. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain Mol. Microbiol. 1990; 497: 1111
  • Singh Y., Chaudhary V. K., Leppla S. H. A deleted variant of Bacillus anthracis protective antigen is non toxic and blocks anthrax toxin action in vivo. J Biol Chem 1989; 264(32)19103
  • Ivins B. E., Welkos S. L. Cloning and expression of Bacillus anthracis protective antigen gene in Bacillus subtilis. Infect.-Immun. 1986; 54: 537
  • Welkos S. L., Lowe J. R., Eden-McCuthan F., Vodkin M., Leppla S. H., Schmidt J. J. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene 1988; 69: 287, 300
  • Tippetts M. T., Robertson D. L. Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase. J Bacteriol. 1988; 170(5)263
  • Robertson D. L., Tipperts M. T., Leppla S. H. Nucleotide sequence of the Bacillus edema factor gene (cya): a calmodulin-dependent adenylate cyclase. Gene 1988; 73(2)363
  • Bragg Robertson T. S.D.L. Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. Gene 1989; 81(1)45
  • Pezard C., Berche P., Mock M. Contribution of Individual Toxin Components to Virulence of Bacillus anthracis. Inf Immun 1991; 59: 3472
  • Smith H., Stoner H. B. Anthrax toxin complex. Fed. Proc. 1967; 26: 1554
  • Green B. D., Battisti L., Koehler T. M., Thorne C. B., Ivins B. E. Demonstration of a Capsule Plasmid in Bacillus anthracis. Infect Immun. 1985; 49: 291
  • Uchida I., Sekizaki T., Hashimoto K., Terakado N. Association of the encapsulation of Bacillus anthracis with a 60megadalton plasmid J. Gen Microbiol. 1985; 131: 363
  • Uchida I. K., Hashimoto K., Makino S., Sasakawa C., Yoshikawa M., Terakado N. Restriction map of a capsule of plasmid of Bacillus anthracis. Plasmid 1987; 18: 178
  • Makino S., Uchida I., Terakado N., Sasakawa C., Yoshikawa M. Molecular Characterization and Protein Analysis of the cap Region. Which is Essential for Encapsulation in Bacillus anthracis. J. Bacteriol. 1989; 171: 722
  • Stepanov A. S. The Molecular Nature of Bacillus anthracis Toxin. Mol. Gen. Mikrobiol. Virusolog. 1991; 1: 3
  • Bail O. Unterschungen uberliche and kunstliche Milzbrand-imunitat. A. Bakteriol. Parasitenk. 1904; 37: 270
  • Cromartie W. J., Bloom W. L., Watson D. W. Studies on infection with Bacillus anthracis I A histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J. Inf. Dis. 1947; 80: 1
  • Cromartie W. J., Watson D. W., Bloom W. L., Heckly R. J. Studies on infection with Bacillus anthracis. II The immunological and tissue damaging properties of extracts prepared from lesions of B. anthracis infection. J. Inf. Dis. 1947; 80: 14
  • Gladstone G. P. Immunity to anthrax: Protective antigen present in cell free culture filtrates. Br. J. Exp. Pathol. 1946; 27: 394, 418
  • Watson D. W., Cromartie W. J., Bloom W. L., Kegeles G., Heckly R. J. Studies on infection with B. anthracis III. Chemical and immunological properties of the protective antigen in crude extracts of skin lesions of B. anthracis. J. Inf. Dis. 1947; 80: 28
  • Smith H., Keppie J. Observations on experimental anthrax: Demonstration of a specific lethal factor produced in vivo by B. anthracis. Nature 1954; 173: 869
  • Harris-Smith P. W., Smith H., Keppie J. Production in vitro of the toxin of Bacillus anthracis previously recognized in vivo. J. Gen Micrtobiol. 1958; 19: 91
  • Wright G. G., Stein J. B. Studies on immunity in anthrax; variation in serum T-agglutinin during anthrax infection in rabbit. J. Exp. Med. 1951; 93: 99
  • Wright G. G., Hedberg M. A., Stein J. B. Studies on immunity in anthrax III. Elaboration of protective antigen in a chemically defined, non protein medium. J. Immunol 1954; 72: 263
  • Stanley J. L., Smith H. The three factors of anthrax toxin: Their immunogenicity and lack of demonstrable enzymatic activity. J. Gen Microbiol. 1962; 31: 329
  • Beall F. A., Taylor M. J., Thorne C. B. Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillur anthracis. J. Bacteriol. 1962; 83: 1274
  • Molnar D. M., Altenbern R. A. Alterations in the Biological Activity of Protective Antigen of Bacillus anthracis Toxin. Proc Soc. Exp. Biol. Med., 114: 294, 196
  • Raziuddin A., Friedlander A. Anthrax Protective Antigen Receptor: Identification of a Protective Antigen Binding Protein by Chemical Cross Linking. Abstract B301 91 Meeting Amer Soc. Microbiol. 1991; 71
  • Escuyer V., Collier J. Anthrax Protective Antigen Interacts with a Specific Receptor on the Surface of CHO-K1 Cells. Inf Immun 1991; 59: 3381
  • Singh Y., Klimpel K. R., Quinn C. P., Chaudhary V. K., Leppla S. H. The carboxyl terminal End of Protective Antigen is Required for Receptor Binding and Anthrax Toxin Activity. J Biol Chem. 1991; 266: 15493
  • Singh Leppla Y., Bhatnagar S. H., Friedlander R. A.M. Internalization and processing of Bacillus anthracis lethal toxin by toxin sensitive and resistant cells. J. Biol Chem. 1989; 264(19)11099
  • Ezzell J. W., Abshire T. G., Little S., Brown C. Analyses of Bacillus anthracis Vegetative Cell Surface Antigens and of Serum Protease Cleavage of Protective Antigen. Proceedings of the International Workshop on Anthrax, P. C.B. Turnbull. Salisbury Printing Co., WilshireUK, 43–44, Salisbury Med. Bull. No.68
  • Ezzell J. W., Abshire T. G. Serum Protease Cleavage of Bacillus anthracis Protective Antigen. J. Gen. Microbiol. 1992
  • Gordon V. M., Young W. W., Lechler S. M., Grey M. C., Leppla S. H., Hewlett E. L. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J. Biol. Chem. 1989; 264: 14792
  • Leppla S. H. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryoltic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984; 17: 189
  • Friedlander A. M. Macrophages are sensitive to anthrax lethal toxin through an acid dependent process. J. Biol. Chem. 1986; 261(16)7123
  • Bhatnagar R., Singh Y., Leppla S. H., Friedlander A. Calcium is Required for the Expression of Anthrax Lethal Toxin Activity in the Macrophagelike. Cell Line 1989; J774A(1)57, 2107
  • O'Brien J., Friedlander Drier A., Ezzell T. J., Leppla S. Effects of anthrax toxin components on human neutrophils. Infect-Immun. 1985; 47(1)306
  • Wade Wright B. H., Hewlet G. G.E.L., Leppla S. H., Mandell G. L. Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils Proc. Soc. Exp. Biol. Med. 1985; 179(2)159
  • Wright G. G., Mandell G. L. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and uramyl dipeptide. J. Exp Med. 1986; 164(5)1700
  • Tafel'shtein E. E., Kalmakov S. V., Chernov A. B., Kondrat'eva A. M., Bashkova V. A. Effect of anthrax toxin on the chemiluminescence of human leucocytes. Biol-Nauki. 1988; 11: 16
  • Welkos S. L., Keener T. J., Gibbs P. H. Differences in susceptibility of inbred mice to Bacillus anthracis. Inf. Immun. 1986; 51: 795
  • Abalakin V. A. Immunosuspressive action of the lethal toxin of Bacillus anthracis in mice. Zh Mikrobiol. Epidemiol. Immunobiol 1989; 6: 94
  • Welkos S. L., Trotter R. W., Becker D. M., Nelson G. O. Resistance to the Sterne strain of Banthracis: phagocytic cell responses of resistant and susceptible mice Microb. Pathog. 1989; 7: 15
  • Ivins B. E., Ezzell Jemski J. W.J., Hedlund K., Ristroph J. D., Leppla S. H. Immunization studies with attenuated strains of Bacillus anthracis. Inf Immun. 1986; 52: 454
  • Ivins B., Welkos S. Recent Advances in the Development of an Improved Human Anthrax Vaccine Eur. J. Epidemiol. 1988; 4: 12
  • Little S., Knudson G. B. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Inf Immun. 1986; 52: 509
  • Turnbull P. C.B., Broster M. G., Carman J. A., Manchee R. J., Melling J. Development of antibodies to protective antiugen and lethal factor components of anthrax toxin in humans and guinea pigs and the relevance to protective immunity. Inf. Immun. 1986; 52: 356
  • Keppie J., Smith H., Harris-Smith P. W. The chemical basis of the virulence of Bacillus anthracis. III The role of the terminal bacteremia in death of guinea pigs from anthrax. Br. J. Exp. Pathol. 1955; 44: 315
  • Klein F., Haines B. W., Mahlandt B. G., De Armon I. A., Lincoln R. E. Dual nature of the resistance mehanisms as revealed by studies of anthrax septicemia. J. Bacteriol. 1963; 85: 1032
  • Sterne M. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. Anim. Indust 1939; 13: 307
  • Sterne M., Nichol J., Lambrechts M. C. The effect of large scale immunization against anthrax J. S. Afr. Vet. Med. Assoc. 1942; 13: 53
  • Marshall E. Sverdlovsk: Anthrax Capital?. Science 1988; 240: 383
  • Brachman S. P., Gold H., Plotkin S. A., Fekety F. R., Werrin M., Ingraham N. R. Field evaluation of a human anthrax vaccine. Am. J. Public Health 1962; 52: 632
  • Fish D. C., Mahlandt B. G., Dobbs J. P, Lincoln R. E. Purification and properties of in vitro produced anthrax toxin components. J. Bacteriol. 1968; 95: 907
  • Stanley J. L., Smith H. Purification of Factor I and recognition of a third fan or of the anthrax toxin. J Gen Microbiol. 1961; 26: 49
  • Mahlandt B. G., Klein F., Lincoln R. E., Haines Jones B. W.W.I., Friedman R. H. Immunological studies of anthrax IV Evalluation of the immunogenicity of three components of anthrax toxin. J. Immunol. 1966; 96: 727
  • Auerbach S., Wright G. C. Studies on immunity in anthrax.VI Immunizing activity of protective antigen against various strains of Bacillus anthracis. J. Immunol 1955; 75: 129
  • Ward M. K., McGann V. G., Hogge A. L., Huff M. L., Kanode R. G., Roberts E. O. Studies on anthrax infections in immunized quinea pigs. J. Inf. Dis. 1965; 115: 59
  • Brachman P. S., Plotkin S. A., Bumford F. H., Atchinson M. N. An epidemic of inhalation anthrax: The first in the twentieth century.II Epidemiology. Am. J. Hyg. 1960; 72: 6
  • Abalakin V. A., Sergeeva L. V., Cherkasova T. D. Purification and characteristics of a protective factor from Bacillus anthracis toxin. Biokhimii 1988; 53: 282
  • Quinn C. P., Shone C. C., Turnbull P. C., Melling J. Purification of anthrax toxin components by high performance anion exchange, gel filtration, and hydrophobic interaction chromatography. Biochem. J. 1988; 252: 753
  • Larson D. K., Calton G. J., Little S. F., Leppla S. H., Burnett J. W. Separation of three exotoxic factors of Bacillus anthracis by sequential immunosorbent. Chromatography 1988; 26: 913
  • Welkos S. L., Friedlander A. M. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb-Pathog. 1988; 5: 127
  • Ivins B. E., Welkos S. L., Knudson G. B., Little S. F. Immunization against Anthrax with Aromatic Compound Dependent (Aro-) Mutants of Bacillus anthracis and with Recombinant Strains of Bacillus subtilis That Produce Anthrax Protective Antigen. Infect Immun. 1990; 58: 303
  • Iacono-Connors L. C., Welkos Ivins S. L.B.E., Dalrymple J. M. Protection against Anthrax with Recombinant Virus Expressed Protective Antigen in Experimental Animals. Infect Immun. 1991; 59: 1961
  • Turnbull P. C.B. Anthrax vaccines:past, present and future. Vaccine 1991; 9: 533
  • Blaustein Koehler R. O., Collier T. M.R.J., Finlelstein A. Anthrax toxin: channel forming activity of protective antigen in planar phospholipid bilayers. Proc. Natl Acad Sci m 1989; 86: 2209
  • Welkos S., Ivins B. Plasmid pX02-associated Differences in Virulence of B. 1991, anthracis Strains Vollum1B and Ames. Abstract B 298 ASM

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.